Get Live Data

Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licensesView Video

Latest Share Chat

  2. Share Prices
  3. ValiRx Share Price
  4. ValiRx Share Regulatory News

Pin to quick picksValiRx Regulatory News (VAL)

ValiRx Information

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.30
Bid: 3.20
Ask: 3.40
Change: -0.15 (-4.35%)
Spread: 0.20 (6.25%)
Open: 3.45
High: 3.45
Low: 3.25
Prev. Close: 3.45
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

456789101112
Date   Source Headline
11th Oct 20177:00 amRNSNotification of US Patent Allowance
5th Oct 20177:00 amRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTotal Voting Rights
28th Sep 20177:00 amRNSValiSeek Clinical Development Update
27th Sep 20173:32 pmRNSHolding(s) in Company
26th Sep 20177:00 amRNSHalf-year Report
20th Sep 20173:18 pmRNSVAL201 update
19th Sep 20177:00 amRNSIssue of Equity
13th Sep 20179:34 amRNSHardman Research: GeneICE and VAL101 progress
7th Sep 20177:00 amRNSGeneICE & VAL101 Update
11th Aug 20177:00 amRNSConvertible Loan Facility
2nd Aug 20177:00 amRNSConversion of Loan Note
28th Jul 20177:00 amRNSLicencing Agreement
22nd Jun 20177:00 amRNSFormation of & Appointments to an Advisory Board
15th Jun 20177:00 amRNSValiSeek Development Update - Recruitment Closes
1st Jun 201711:00 amRNSYorkville CLN Conversion
31st May 201711:00 amRNSHardman Research:Developing novel cancer therapies
30th May 201710:34 amRNSResult of AGM
24th May 20177:00 amRNSNOTIFICATION OF AUSTRALIAN PATENT ALLOWANCE
5th May 20175:28 pmRNSNotice of AGM
5th May 20177:00 amRNSFinal Results
27th Apr 201710:07 amRNSRe: SHARES Magazine Supplement on ValiRx website
19th Apr 20179:00 amRNSChange of Registered Office
15th Mar 20179:33 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amRNSValiSeek Clinical Development Update
2nd Mar 20177:00 amRNSDirector/PDMR Shareholding
1st Mar 20171:37 pmRNSPlacing to raise £1.16m and Proposed Subscription
28th Feb 20177:00 amRNSPublication of Peer-Reviewed Articles on VAL401
11th Jan 20177:00 amRNSCLINICAL TRIAL UPDATE - Positive VAL201 Results
30th Dec 20167:00 amRNSYorkville CLN Conversion
8th Dec 20167:00 amRNSEuropean Patent Granted for Lead Compound VAL201
2nd Dec 20164:15 pmRNSConvertible Loan Facility
1st Dec 20167:00 amRNSValiSeek Clinical Development Update
29th Nov 20167:00 amRNSQuarterly Update on Clinical Developments
3rd Nov 20167:00 amRNSValiSeek Clinical Development Update
28th Oct 20169:00 amRNSCorporate Video re Clinical Status Q4, 2016
25th Oct 20167:00 amRNSPatent Update
13th Oct 20164:20 pmRNSHolding(s) in Company
13th Oct 20164:20 pmRNSHolding(s) in Company
13th Oct 20167:00 amRNSUpdate on Recent Presentations
12th Oct 201611:15 amRNSResult of General Meeting
5th Oct 20163:42 pmRNSCLN Conversion
28th Sep 201611:09 amRNSNotice of GM
27th Sep 20167:00 amRNSHalf-year Report
26th Sep 20167:00 amRNSValiRx selected for The Parliamentary Review 2016
13th Sep 20167:00 amRNSQuarterly Update on Clinical Developments
2nd Sep 20162:10 pmRNSPlacing, issue of warrants & Convertible Loan
11th Aug 20167:00 amRNSValiSeek Clinical Development Update
4th Aug 201611:32 amRNSIssue of Equity
28th Jul 20167:00 amRNSNotification of New Zealand Patent Grant Allowance
456789101112

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.